Drug-related Halitosis: A Systematic Review

被引:5
作者
Mortazavi, Hamed [1 ]
Nobar, Behrad Rahbani [2 ]
Shafiei, Shervin [3 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Dent, Dept Oral Med, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Sch Dent, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Sch Dent, Dept Oral & Maxillofacial Surg, Tehran, Iran
关键词
adverse drug events; adverse drug reactions; drug side effects; extra-oral halitosis; halitosis; TOPICAL DICLOFENAC SOLUTION; PHASE-I; DIMETHYL-SULFOXIDE; DOUBLE-BLIND; PRIMARY OSTEOARTHRITIS; CYSTINOSIS PATIENTS; RELEASE CYSTEAMINE; EFFICACY; INHIBITOR; MALODOR;
D O I
10.3290/j.ohpd.a44679
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Purpose: Halitosis is an unpleasant breath odor which can be bothersome to individuals. Extra-oral halitosis is a type of halitosis caused by systemic conditions, bloodborne diseases, or pharmaceutical therapy. It is not related to local factors in the oral cavity. This systematic review aimed to identify the medications that can cause extra-oral halitosis. Materials and Methods: This study was conducted in accordance with the preferred reporting items for systematic reviews and meta-analyses (PRISMA). We searched online databases and also included hand searching to find relevant articles. Two authors independently performed the screening, data extraction and quality assessment of the included articles using the Cochrane Collaboration assessment tool. Results: Thirty-four studies met the eligibility criteria. The medications which can cause extra-oral halitosis were categorised into 10 groups: acid reducers, aminothiols, anticholinergics, antidepressants, antifungals, antihistamines and steroids, antispasmodics, chemotherapeutic agents, dietary supplements, and organosulfur substances. Conclusion: Pharmaceutical therapy is a potential source of extra-oral halitosis. This finding can help clinicians detect the probable causes of halitosis. Further studies are needed to definitely determine the role of various medications in causing extra-oral halitosis.
引用
收藏
页码:399 / 407
页数:9
相关论文
共 56 条
  • [21] Effect of omega 3 fatty acids plus low-dose aspirin on both clinical and biochemical profiles of patients with chronic periodontitis and type 2 diabetes: a randomized double blind placebo-controlled study
    Elwakeel, N. M.
    Hazaa, H. H.
    [J]. JOURNAL OF PERIODONTAL RESEARCH, 2015, 50 (06) : 721 - 729
  • [22] A phase I and pharmacokinetic study of fixed-dose selenomethionine and irinotecan in solid tumors
    Fakih, MG
    Pendyala, L
    Smith, PF
    Creaven, PJ
    Reid, ME
    Badmaev, V
    Azrak, RG
    Prey, JD
    Lawrence, D
    Rustum, YM
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (04) : 1237 - 1244
  • [23] Breaking paradigms: a new definition for halitosis in the context of pseudo-halitosis and halitophobia
    Falcao, Denise Pinheiro
    Vieira, Celi Novaes
    Batista de Amorim, Rivadavio Fernandes
    [J]. JOURNAL OF BREATH RESEARCH, 2012, 6 (01)
  • [24] A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients
    Flaig, Thomas W.
    Gustafson, Daniel L.
    Su, Lih-Jen
    Zirrolli, Joseph A.
    Crighton, Frances
    Harrison, Gail S.
    Pierson, A. Scott
    Agarwal, Rajesh
    Glode, L. Michael
    [J]. INVESTIGATIONAL NEW DRUGS, 2007, 25 (02) : 139 - 146
  • [25] Tolerability of omega-3 fatty acid supplements in perinatal women
    Freeman, Marlene P.
    Sinha, Priti
    [J]. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2007, 77 (3-4): : 203 - 208
  • [26] Updating the evidence on drugs to treat overactive bladder: a systematic review
    Hsu, Frances C.
    Weeks, Chandler E.
    Selph, Shelley S.
    Blazina, Ian
    Holmes, Rebecca S.
    McDonagh, Marian S.
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2019, 30 (10) : 1603 - 1617
  • [27] Identifying adverse drug events: Development of a computer-based monitor and comparison with chart review and stimulated voluntary report
    Jha, AK
    Kuperman, GJ
    Teich, JM
    Leape, L
    Shea, B
    Rittenberg, E
    Burdick, E
    Seger, DL
    Vander Vliet, M
    Bates, DW
    [J]. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 1998, 5 (03) : 305 - 314
  • [28] Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients.: A randomized controlled trial
    Kaviani, MJ
    Malekzadeh, R
    Vahedi, H
    Sotoudeh, M
    Kamalian, N
    Amini, M
    Massarrat, S
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2001, 13 (08) : 915 - 919
  • [29] The gastrointestinal aspects of halitosis
    Kinberg, Sivan
    Stein, Miki
    Zion, Nataly
    Shaoul, Ron
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 24 (09): : 552 - 556
  • [30] The Prevention and Treatment of Missing Data in Clinical Trials
    Little, Roderick J.
    D'Agostino, Ralph
    Cohen, Michael L.
    Dickersin, Kay
    Emerson, Scott S.
    Farrar, John T.
    Frangakis, Constantine
    Hogan, Joseph W.
    Molenberghs, Geert
    Murphy, Susan A.
    Neaton, James D.
    Rotnitzky, Andrea
    Scharfstein, Daniel
    Shih, Weichung J.
    Siegel, Jay P.
    Stern, Hal
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (14) : 1355 - 1360